Overview

A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Status:
Unknown status
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Comparison of two combination chemotherapies in the treatment of patients with SLCL
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Charite University, Berlin, Germany
Collaborators:
Aventis Pharmaceuticals
Pfizer
Treatments:
Carboplatin
Etoposide
Etoposide phosphate
Irinotecan